Ascension Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.36M | Hold |
7,115
| – | – | 0.71% | 52 |
|
|
2024
Q1 | $1.41M | Buy |
+7,115
| New | +$1.41M | 0.76% | 54 |
|
|
2023
Q2 | $3.19M | Buy |
+14,586
| New | +$3.19M | 1.95% | 11 |
|
|
2022
Q4 | $3.04M | Sell |
14,586
-25
| -0.2% | -$5.2K | 2.19% | 7 |
|
|
2022
Q3 | $3.18M | Hold |
14,611
| – | – | 2.5% | 7 |
|
|
2022
Q2 | $3.06M | Buy |
+14,611
| New | +$3.06M | 2.26% | 7 |
|
|
2021
Q4 | $3.84M | Sell |
14,752
-200
| -1% | -$52.1K | 2.28% | 10 |
|
|
2021
Q3 | $3.94M | Hold |
14,952
| – | – | 2.58% | 8 |
|
|
2021
Q2 | $3.69M | Sell |
14,952
-250
| -2% | -$61.6K | 2.41% | 9 |
|
|
2021
Q1 | $2.95M | Buy |
+15,202
| New | +$2.95M | 2.07% | 11 |
|
|
2020
Q4 | – | Sell |
-15,727
| Closed | -$2.7M | – | 86 |
|
|
2020
Q3 | $2.7M | Buy |
+15,727
| New | +$2.7M | 2.16% | 11 |
|
|
2020
Q1 | $2.33M | Buy |
15,785
+100
| +0.6% | +$14.7K | 2.41% | 7 |
|
|
2019
Q4 | $2.43M | Hold |
15,685
| – | – | 2.1% | 11 |
|
|
2019
Q3 | $2.12M | Sell |
15,685
-1,275
| -8% | -$172K | 1.96% | 16 |
|
|
2019
Q2 | $2.07M | Hold |
16,960
| – | – | 1.82% | 17 |
|
|
2019
Q1 | $1.76M | Sell |
16,960
-200
| -1% | -$20.8K | 1.58% | 24 |
|
|
2018
Q4 | $1.95M | Hold |
17,160
| – | – | 1.98% | 14 |
|
|
2018
Q3 | $1.98M | Buy |
17,160
+60
| +0.4% | +$6.92K | 1.74% | 18 |
|
|
2018
Q2 | $1.77M | Buy |
17,100
+650
| +4% | +$67.3K | 1.62% | 26 |
|
|
2018
Q1 | $1.62M | Hold |
16,450
| – | – | 1.48% | 27 |
|
|
2017
Q4 | $1.39M | Buy |
+16,450
| New | +$1.39M | 1.27% | 34 |
|